The MCO-19M also introduces the option of a hydrogen peroxide decontamination system that enables full decontamination and incubator cleaning to be completed in less than a morning.
Incorporating Sanyo’s proprietary single-beam, dual detector infrared CO2 sensor, the MCO-19M delivers precise CO2 control and continuous zero calibration. The solid state CO2 sensor is not affected by humidity or temperature changes and has no moving parts, thereby improving reliability. O2 is measured using a solid state zirconium sensor. Sub-ambient O2 levels can be maintained from 1–18% and enriched levels from 22–80%, simultaneously with a CO2 range from 0–20%.
The incubator also uses Sanyo’s patented direct heat and air jacket conditioning system. With multiple heating zones under microprocessor control, the temperature throughout the chamber is precisely regulated.
The InCu saFe copper-enriched stainless steel interior continuously inhibits growth of moulds, fungi, mycoplasma and bacteria and with the optional patented SafeCell UV system, airborne and water contaminants are eliminated without harming cell cultures.
Other features of the MCO-19M include an automatic gas switchover system that changes from the primary to a secondary gas cylinder for either oxygen or nitrogen, and an optional secondary gas switchover system for CO2, ensuring continuity of supply. There is also a newly designed multiple glass inner door system which makes it unnecessary for the door to be fully opened when removing cell cultures.
Sanyo incubator offers uniform culturing environment
Includes optional hydrogen peroxide decontamination system
You may also like
Trending Articles
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months